Research Project

Project Title:	A PHASE III, RANDOMIZED, OPEN-LABEL ACTIVE COMPARATOR-CONTROLLED MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH PRIMARY MEMBRANOUS NEPHROPATHY
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Immune glomerulopathies
Project Summary:	This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics of obinutuzumab compared with tacrolimus in patients with primary membranous nephropathy (pMN).
Lead principal investigator(s):	Loreto Gesualdo, Bari
Co-investigator(s):	Marica Giliberti, Bari Anna Maria Di Palma, Bari Daniele Cappiello, Bari
Project Period:	09/2021 - 06/2028
Sponsors:	Industry
ClinicalTrials.gov:	NCT04629248